MELATONIN
Information current as at: 1 June 2025
The pharmaceutical company has advised that it is not proceeding in the PBS listing process at this time. The process for listing this medicine has ceased.
Submission Details
- Brand name:
-
- Slenyto®
- Pharmaceutical company:
- Aspen Pharmacare Australia Pty Ltd
- Condition/indication:
(therapeutic use) -
- Insomnia
- PBAC Submission type:
- New listing (–)
- Comment:
- Item was considered by PBAC between its July 2021 and November 2021 meeting. No further action, please see MELATONIN link in Related medicines below.
- Public Summary Document:
- Public Summary Documents – November 2021
Progress Details
-
Submission received for:: - November 2021 PBAC meeting
-
Opportunity for consumer comment: - Open 28/07/2021 and close 22/09/2021 (see PBS Website)
-
PBAC meeting: - Held on 03/11/2021
-
Lodgement of required documentation: - 23/12/2021
-
Acceptance of complete documentation:
- Not Accepted
-
Agreement to listing arrangements: - Not applicable
-
Government processes: - Not applicable
-
Medicine listed on the PBS: - Not applicable
Case ID: a510
Page last updated: 31 December 2024